Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Tesla
TSLA
|
+$378M |
| 2 |
AT&T
T
|
+$328M |
| 3 |
Roku
ROKU
|
+$326M |
| 4 |
Qualcomm
QCOM
|
+$269M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$255M |
Top Sells
| 1 |
Baidu
BIDU
|
+$1.17B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$727M |
| 3 |
Pinduoduo
PDD
|
+$599M |
| 4 |
AbbVie
ABBV
|
+$564M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$483M |
Sector Composition
| 1 | Healthcare | 19.43% |
| 2 | Technology | 17.52% |
| 3 | Communication Services | 11.2% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Consumer Staples | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Rexford Industrial Realty
REXR
$10.1B
| $7.85M | 0.01% |
155,800
+129,100
| +484% | +$6.51M |
|
|
RFP
1352
DELISTED
Resolute Forest Products Inc.
RFP
| $7.84M | 0.01% |
715,900
-160,400
| -18% | -$1.76M |
|
1353
Anywhere Real Estate
HOUS
$763M
| $7.83M | 0.01% |
517,700
-833,992
| -62% | -$12.6M |
|
1354
Manhattan Associates
MANH
$12.8B
| $7.8M | 0.01% |
66,460
-176,400
| -73% | -$20.7M |
|
1355
Harvard Bioscience
HBIO
$20M
| $7.8M | 0.01% |
1,427,645
+211,200
| +17% | +$1.15M |
|
1356
Gates Industrial
GTES
$6.52B
| $7.77M | 0.01% |
486,000
+302,500
| +165% | +$4.84M |
|
1357
Consolidated Water Co
CWCO
$524M
| $7.76M | 0.01% |
576,667
-74,746
| -11% | -$1.01M |
|
|
CHNG
1358
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $7.75M | 0.01% |
+350,704
| New | +$7.75M |
|
1359
DURECT Corp
DRRX
$59.3M
| $7.73M | 0.01% |
390,190
-87,503
| -18% | -$1.73M |
|
|
PVG
1360
DELISTED
PRETIUM RESOURCES INC.
PVG
| $7.72M | 0.01% |
744,300
+588,319
| +377% | +$6.1M |
|
1361
Core Molding Technologies
CMT
$180M
| $7.7M | 0.01% |
656,664
+19,810
| +3% | +$232K |
|
|
QUMU
1362
DELISTED
Qumu Corp.
QUMU
| $7.7M | 0.01% |
1,138,515
+45,841
| +4% | +$310K |
|
1363
Zions Bancorporation
ZION
$8.56B
| $7.68M | 0.01% |
139,795
-257,500
| -65% | -$14.2M |
|
|
MN
1364
DELISTED
MANNING & NAPIER, INC.
MN
| $7.68M | 0.01% |
1,186,268
-2,300
| -0.2% | -$14.9K |
|
1365
Grupo Aval
AVAL
$4.02B
| $7.66M | 0.01% |
1,230,668
-170,649
| -12% | -$1.06M |
|
|
FRSX
1366
Foresight Autonomous Holdings
FRSX
$8.24M
| $7.65M | 0.01% |
+29,148
| New | +$7.65M |
|
|
TACO
1367
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $7.65M | 0.01% |
798,062
+268,434
| +51% | +$2.57M |
|
|
ESSA
1368
DELISTED
ESSA Bancorp
ESSA
| $7.64M | 0.01% |
477,705
+1,877
| +0.4% | +$30K |
|
|
AE
1369
DELISTED
Adams Resources & Energy Inc.
AE
| $7.63M | 0.01% |
272,238
-7,200
| -3% | -$202K |
|
1370
Gencor Industries
GENC
$225M
| $7.61M | 0.01% |
567,660
+22,413
| +4% | +$301K |
|
1371
Neurogene
NGNE
$265M
| $7.61M | 0.01% |
30,897
-7,238
| -19% | -$1.78M |
|
|
TMX
1372
DELISTED
Terminix Global Holdings, Inc.
TMX
| $7.6M | 0.01% |
159,500
-30,000
| -16% | -$1.43M |
|
1373
OraSure Technologies
OSUR
$238M
| $7.58M | 0.01% |
649,503
-509,200
| -44% | -$5.94M |
|
1374
Atara Biotherapeutics
ATRA
$82.7M
| $7.56M | 0.01% |
21,044
+20,220
| +2,454% | +$7.26M |
|
1375
Vanguard FTSE Developed Markets ETF
VEA
$175B
| $7.54M | 0.01% |
+153,500
| New | +$7.54M |
|